ocal and oral management of Shushkakshipaka w.s.r. Meibomian glands dysfunctio
Not Applicable
- Conditions
- Health Condition 1: H028- Other specified disorders of eyelid
- Registration Number
- CTRI/2019/06/019859
- Lead Sponsor
- RISHIKUL CAMPUS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients presenting with signs and symptoms of Shushkakshipaka and meibomian Gland Dysfunction
2. Age 20-60 years
3. Visual acuity 6/6 both eyes, with or without glasses.
Exclusion Criteria
1. Patient having visual acuity < 6/6 & N6 with or without glasses
2. Patient having infective anterior segment disorders, lid disorders etc.
3. Patient suffering from specific eye lid disorders like tumor, skin allergies (acne rosacae), ectropion, entropion, lagophthalmos, aqueous deficiency dry eye etc.
4. Systemic diseases like DM, HTN, RA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity. <br/ ><br>Complete remission- more than 90% <br/ ><br>Maximum improvement-76-90% <br/ ><br>Moderate improvement-51-75% <br/ ><br>Mild improvement-26-50% <br/ ><br>no improvement- less than 25%Timepoint: The effect of therapy will be observed during first day of trial, at 15th day of trial and on the 30th day of trial.
- Secondary Outcome Measures
Name Time Method Excerbation in signs and symptomsTimepoint: 1 month